ACOR — Acorda Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Acorda Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	126	71.4	45.6	37.5	30
Net Total Accounts Receivable
Net Total Receivables	22.1	20.2	17	13.9	17.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	201	221	102	82.1	74.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	166	25.7	11.1	7.89	6.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	800	633	455	396	109
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	86.4	137	54	38	228
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	489	395	304	302	266
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	311	238	151	93.6	-158
Total Liabilities & Shareholders' Equity	800	633	455	396	109
Total Common Shares Outstanding